Key result
CKD shows no significant difference in 12-month AF-free survival after pulsed field ablation.
Why the study?
AF and CKD are prevalent conditions with shared risk factors, but safety and efficacy of pulsed field ablation for AF in CKD patients were not well characterized.
Cohort (n=2,269)
Answers are grounded in this paper and cite their sources.
Cohort study finds similar rhythm control but higher acute kidney injury after pulsed field ablation in kidney disease, indicating a need for careful periprocedural renal management.
BACKGROUND: Atrial fibrillation (AF) and chronic kidney disease (CKD) are prevalent conditions linked by multiple shared risk factors. OBJECTIVE: This study aimed to compare periprocedural safety and long-term efficacy outcomes of pulsed field ablation (PFA) for AF in patients with and without CKD. METHODS: Consecutive patients from a major health system in the United States were included in the analysis. RESULTS: A total of 2,269 patients were included: 1,829 without CKD, 314 with mild CKD, 103 with moderate CKD, and 23 with advanced CKD. Mean age was 66.9 (±10.2) years and 716 (31.6%) patients were female. Non-renal procedural complications occurred in 5.9% of patients; after multivariable adjustment, no CKD category was independently associated with this outcome. AKI occurred in 4.9% of patients with available post-procedural renal function data. A decreased eGFR was independently associated with AKI (OR 0.96, 95% CI 0.94-0.99 P<0.01). Estimated 12-month AF-free survival was comparable between patients with and without CKD (HR 1.20; 95% CI 0.93-1.59; P=0.1). CONCLUSION: PFA for AF is feasible in patients with CKD. However, patients with a decreased eGFR had a significantly higher risk of AKI and presented a numerically higher rate of non-renal complications.
No takes yet. Share an insight, caveat, or question.
Rodriguez et al. (2026) conducted a cohort in Atrial fibrillation (n=2,269). Chronic kidney disease vs. No chronic kidney disease was evaluated on 12-month AF-free survival (HR 1.20, 95% CI 0.93-1.59, p=0.1). In patients undergoing pulsed field ablation for atrial fibrillation, chronic kidney disease was associated with comparable 12-month AF-free survival versus no CKD.
Synapse has enriched 10 related papers. Consider them for comparative context: